Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

An Analytical Model for BDS B1 Spreading Code Self-Interference Evaluation Considering NH Code Effects.

Zhang X, Zhan X, Feng S, Ochieng W.

Sensors (Basel). 2017 Mar 23;17(4). pii: E663. doi: 10.3390/s17040663.

2.

Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure.

Kimulwo MJ, Okendo J, Aman RA, Ogutu BR, Kokwaro GO, Ochieng DJ, Muigai AW, Oloo FA, Ochieng W.

PLoS One. 2017 Feb 24;12(2):e0172960. doi: 10.1371/journal.pone.0172960. eCollection 2017.

3.

Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.

Kitawi RC, Hunja CW, Aman R, Ogutu BR, Muigai AW, Kokwaro GO, Ochieng W.

Virol J. 2017 Feb 14;14(1):29. doi: 10.1186/s12985-017-0703-y.

4.

Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR; HPTN 052 Study Team.

N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.

5.

Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.

Mwatelah RS, Lwembe RM, Osman S, Ogutu BR, Aman R, Kitawi RC, Wangai LN, Oloo FA, Kokwaro GO, Ochieng W.

PLoS One. 2015 Jul 24;10(7):e0132287. doi: 10.1371/journal.pone.0132287. eCollection 2015.

6.

Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy.

Ochieng W, Kitawi RC, Nzomo TJ, Mwatelah RS, Kimulwo MJ, Ochieng DJ, Kinyua J, Lagat N, Onyango KO, Lwembe RM, Mwamburi M, Ogutu BR, Oloo FA, Aman R.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e49-56. doi: 10.1097/QAI.0000000000000580.

7.

The impact of airport characteristics on airport surface accidents and incidents.

Wilke S, Majumdar A, Ochieng WY.

J Safety Res. 2015 Jun;53:63-75. doi: 10.1016/j.jsr.2015.03.006. Epub 2015 Apr 1.

PMID:
25933999
8.

Modelling runway incursion severity.

Wilke S, Majumdar A, Ochieng WY.

Accid Anal Prev. 2015 Jun;79:88-99. doi: 10.1016/j.aap.2015.03.016. Epub 2015 Mar 24.

PMID:
25819211
9.

Genotypic Variability of HIV-1 Reverse Transcriptase Gene from Long-Term Antiretroviral-Experienced Patients in Kenya.

Nzomo TJ, Kitawi RC, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Okendo J, Lwembe RM, Ogutu B, Muigai A, Ochieng W.

AIDS Res Hum Retroviruses. 2015 May;31(5):550-3. doi: 10.1089/AID.2015.0031. Epub 2015 Mar 31.

10.

HIV-1 subtype diversity based on envelope C2V3 sequences from Kenyan patients on highly active antiretroviral therapy.

Kitawi RC, Nzomo T, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Lwembe RM, Okendo J, Ogutu B, Ochieng W.

AIDS Res Hum Retroviruses. 2015 Apr;31(4):452-5. doi: 10.1089/AID.2014.0306. Epub 2014 Dec 18.

PMID:
25423998
11.

Motion field estimation for a dynamic scene using a 3D LiDAR.

Li Q, Zhang L, Mao Q, Zou Q, Zhang P, Feng S, Ochieng W.

Sensors (Basel). 2014 Sep 9;14(9):16672-91. doi: 10.3390/s140916672.

12.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C; Partners PrEP Study Team.

N Engl J Med. 2012 Aug 2;367(5):399-410. doi: 10.1056/NEJMoa1108524. Epub 2012 Jul 11.

13.

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA, Simmerman JM, Gordon A, Sato M, Howie S, Krishnan A, Ope M, Lindblade KA, Carosone-Link P, Lucero M, Ochieng W, Kamimoto L, Dueger E, Bhat N, Vong S, Theodoratou E, Chittaganpitch M, Chimah O, Balmaseda A, Buchy P, Harris E, Evans V, Katayose M, Gaur B, O'Callaghan-Gordo C, Goswami D, Arvelo W, Venter M, Briese T, Tokarz R, Widdowson MA, Mounts AW, Breiman RF, Feikin DR, Klugman KP, Olsen SJ, Gessner BD, Wright PF, Rudan I, Broor S, Simões EA, Campbell H.

Lancet. 2011 Dec 3;378(9807):1917-30. doi: 10.1016/S0140-6736(11)61051-9. Epub 2011 Nov 10. Review.

PMID:
22078723
14.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.

Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8.

15.

Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.

Lihana RW, Lwembe RM, Bi X, Ochieng W, Panikulam A, Palakudy T, Musoke R, Owens M, Ishizaki A, Okoth FA, Songok EM, Ichimura H.

J Clin Virol. 2011 Oct;52(2):123-8. doi: 10.1016/j.jcv.2011.06.014. Epub 2011 Jul 27.

PMID:
21798798
16.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team.

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.

17.

Genetic diversity of HIV type 1 along the coastal strip of Kenya.

Khamadi SA, Lihana RW, Osman S, Mwangi J, Muriuki J, Lagat N, Kinyua J, Mwau M, Kageha S, Okoth V, Ochieng W, Okoth FA.

AIDS Res Hum Retroviruses. 2009 Sep;25(9):919-23. doi: 10.1089/aid.2009.0005.

PMID:
19751145
18.

Susceptibility to Simian immunodeficiency virus ex vivo predicts outcome of a prime-boost vaccine after SIVmac239 challenge.

Ochieng W, Sauermann U, Schulte R, Suh YS, Kim KS, Sung YC, Hunsmann G, Stahl-Hennig C, Sopper S.

J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):162-9. doi: 10.1097/QAI.0b013e3181b22f4a.

PMID:
19644382
19.

Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya.

Bulimo WD, Garner JL, Schnabel DC, Bedno SA, Njenga MK, Ochieng WO, Amukoye E, Magana JM, Simwa JM, Ofula VO, Lifumo SM, Wangui J, Breiman RF, Martin SK.

Influenza Other Respir Viruses. 2008 May;2(3):107-13. doi: 10.1111/j.1750-2659.2008.00044.x.

20.

The changing trend of HIV type 1 subtypes in Nairobi.

Lihana RW, Khamadi SA, Lwembe RM, Ochieng W, Kinyua JG, Kiptoo MK, Muriuki JK, Lagat N, Osman S, Mwangi JM, Okoth FA, Songok EM.

AIDS Res Hum Retroviruses. 2009 Mar;25(3):337-42. doi: 10.1089/aid.2008.0228.

PMID:
19327052

Supplemental Content

Loading ...
Support Center